Literature DB >> 6871837

Involvement of chromosomes 7 and 12 in large bowel cancer: trisomy 7 and 12q-.

R Becher, Z Gibas, A A Sandberg.   

Abstract

Cytogenetic analysis of an adenocarcinoma of the large bowel with some villous features revealed consistent chromosome changes: trisomy of chromosomes No. 7, 12, and 20 and a deletion of part of the long arm of a chromosome No. 12. Examination of the chromosome findings in previously published cases of large bowel cancers and the data presented in this paper lead us to suggest that trisomy No. 7 and 12q- may be nonrandom (primary) karyotypic changes in a subgroup of large bowel cancers.

Entities:  

Mesh:

Year:  1983        PMID: 6871837     DOI: 10.1016/0165-4608(83)90080-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Cytogenetic, oncogenetic, and histopathologic characteristics of colorectal carcinomas with 17p abnormalities.

Authors:  D Rau; S Neubauer; A Köster; J Giedl; R Sachse; S Landgraf; A Leipold; T Dingermann; E Gebhart
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

2.  Chromosomal markers in study of colon cancer.

Authors:  S R Wolman
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

3.  Detection of ploidy in colorectal tumors. A comparison between flow cytometry and cytogenetics.

Authors:  A Laquerriere; P Peulve; M A Scotte; S X Ma; M Paresy; P Teniere; J Hemet
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

4.  Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney.

Authors:  S Knuutila; M L Larramendy; P Elfving; W el-Rifai; A Miettinen; F Mitelman
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

Review 5.  Safety of using cultured cells with trisomy 7 in cell therapy for treating osteoarthritis.

Authors:  Mitsuru Mizuno; Nobutake Ozeki; Ichiro Sekiya
Journal:  Regen Ther       Date:  2022-06-17       Impact factor: 3.651

6.  Cancer cells preferentially lose small chromosomes.

Authors:  Pascal H G Duijf; Nikolaus Schultz; Robert Benezra
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.